Analysts on Wall Street project that Macerich (MAC) will announce quarterly earnings of $0.31 per share in its forthcoming report, representing no change year over year. Revenues are projected to reach $218.91 million, increasing 4.9% from the same quarter last year. The consensus EPS estimate for the quarter has undergone a downward revision of 0.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. That said, let's delve into the average estimates of some Macerich metrics that Wall Street analysts commonly model and monitor. The collective assessment of analysts points to an estimated 'Leasing Revenue- Minimum rents' of $133.74 million. The estimate indicates a change of +5.2% from the prior-year quarter. Analysts' assessment points toward 'Management Companies revenues' reaching $7.36 million. The estimate suggests a change of -10.6% year over year. Analysts expect 'Leasing Revenue- Tenant recoveries' to come in at $59.11 million. The estimate indicates a change of +1.9% from the prior-year quarter. Analysts forecast 'Depreciation and amortization' to reach $70.92 million. The estimate compares to the year-ago value of $68.35 million. View all Key Company Metrics for Macerich here>>> Shares of Macerich have demonstrated returns of +12% over the past month compared to the Zacks S&P 500 composite's +10.6% change. With a Zacks Rank #3 (Hold), MAC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Macerich Company (The) (MAC):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Countdown to Macerich (MAC) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...